Exploratory biomarker analysis in avelumab-treated patients with metastatic Merkel cell carcinoma progressed after chemotherapy.

被引:3
|
作者
Shapiro, Irina
Grote, Hans Juergen
D'Urso, Vittorio
von Heydebreck, Anja
Mahnke, Lisa
Kaufman, Howard
Nghiem, Paul
Cal, Ti
机构
关键词
D O I
10.1200/JCO.2017.35.15_suppl.9557
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
9557
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Tereza Lanitis
    Irina Proskorovsky
    Apoorva Ambavane
    Matthias Hunger
    Ying Zheng
    Murtuza Bharmal
    Hemant Phatak
    Advances in Therapy, 2019, 36 : 2327 - 2341
  • [2] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Lanitis, Tereza
    Proskorovsky, Irina
    Ambavane, Apoorva
    Hunger, Matthias
    Zheng, Ying
    Bharmal, Murtuza
    Phatak, Hemant
    ADVANCES IN THERAPY, 2019, 36 (09) : 2327 - 2341
  • [3] 18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy.
    D'Angelo, Sandra P.
    Russell, Jeffery Scott
    Bhatia, Shailender
    Hamid, Omid
    Mehnert, Janice M.
    Terheyden, Patrick
    Shih, Kent C.
    Brownell, Isaac
    Lebbe, Celeste
    Lewis, Karl D.
    Linette, Gerald P.
    Milella, Michele
    Hennessy, Meliessa
    Bajars, Marcis
    Zwiener, Isabella
    Nghiem, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [4] Lethal thrombocytopenia in a patient treated with avelumab for metastatic Merkel cell carcinoma
    Kratzsch, Dorothea
    Simon, Jan-Christoph
    Poenitzsch, Iris
    Ziemer, Mirjana
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 (01): : 73 - 75
  • [5] BUDGET IMPACT ANALYSIS OF AVELUMAB IN PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN THE US
    Bharmal, M.
    D'Angelo, S. P.
    Phatak, H.
    VALUE IN HEALTH, 2017, 20 (09) : A424 - A424
  • [6] Avelumab treatment in chemotherapy-naive patients with distant metastatic Merkel cell carcinoma (mMCC)
    D'Angelo, S. P.
    Russell, J.
    Hassel, J.
    Lebbe, C.
    Chmielowski, B.
    Rabinowits, G.
    Terheyden, P.
    Brownell, I.
    Zwiener, I.
    Bajars, M.
    Hennessy, M.
    Kaufman, H. L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Avelumab in chemotherapy-refractory metastatic Merkel cell carcinoma: Subgroup analysis of efficacy.
    Kaufman, Howard L.
    Russell, Jeffrey
    Hamid, Omid
    Bhatia, Shailender
    Terheyden, Patrick
    D'Angelo, Sandra P.
    Shih, Kent C.
    Lebbe, Celeste
    Linette, Gerald P.
    Milella, Michele
    Brownell, Isaac
    Lewis, Karl D.
    Lorch, Jochen H.
    von Heydebreck, Anja
    Mahnke, Lisa
    Nghiem, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [8] Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma
    Hu, Ping
    Dai, Haiqing Isaac
    Bourdage, James
    Zhou, Dongli
    Trang, Ky
    Kowalski, Karey
    Bello, Carlo
    Hibma, Jennifer
    Khandelwal, Akash
    Cowan, Kyra
    Dong, Jennifer
    Venkatakrishnan, Karthik
    Gao, Wei
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [9] Two-Year Efficacy and Safety Update from JAVELIN Merkel 200 Part A: A Registrational Study of Avelumab in Metastatic Merkel Cell Carcinoma Progressed on Chemotherapy
    Sandhu, S.
    Nghiem, P.
    Bhatia, S.
    Brohl, A. S.
    Hamid, O.
    Mehnert, J. M.
    Terheyden, P.
    Shih, K. C.
    Brownell, I.
    Lebbe, C.
    Lewis, K. D.
    Linette, G. P.
    Milella, M.
    Hennessy, M.
    Bajars, M.
    Hicking, C.
    D'Angelo, S. P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 52 - 53
  • [10] Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Nghiem, Paul
    Bhatia, Shailender
    Brohl, Andrew Scott
    Hamid, Omid
    Mehnert, Janice M.
    Terheyden, Patrick
    Shih, Kent C.
    Brownell, Isaac
    Lebbe, Celeste
    Lewis, Karl D.
    Linette, Gerald P.
    Milella, Michele
    Hennessy, Meliessa
    Bajars, Marcis
    Hicking, Christine
    D'Angelo, Sandra P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)